Lymphoma p53 Hotspot Mutation Cell Panel (ATCC® TCP-2050)

Organism: Homo sapiens, human  / 

Permits and Restrictions

View Permits

Organism Homo sapiens, human
Components EB-3,  ATCC CCL-85
CA46,  ATCC CRL-1648
Namalwa,  ATCC CRL-1432
DB,  ATCC CRL-2289
SUP-T1,  ATCC CRL-1942
Applications Biological understanding of top genetic alterations in lymphoma
Novel anti-cancer drug targeting
Reactivation of mutant p53
Studies related to p53 molecular mechanisms
Testing small molecules or biologics for cancer drug development
Biosafety Level 2   [Cells contain herpes virus]

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Comments

The Lymphoma p53 Hotspot Mutation Cell Panel is comprised of five select suspension cell lines derived from lymphomas. Mutations have been sequenced and validated by ATCC. This panel includes a cell line with WT p53 as well as cell lines with p53 hotspot mutations at codons 248 and 273

Product Format 5 cryopreserved cell lines
Storage Conditions liquid nitrogen vapor phase
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Other Documentation